The Case For A New Paradigm In Geographic Atrophy Clinical Trials: Leveraging Genetics, Smarter Endpoints, And Artificial Intelligence Clinical Leader
- Home
- Press Release
- The Case For A New Paradigm In Geographic Atrophy Clinical Trials: Leveraging Genetics, Smarter Endpoints, And Artificial Intelligence – Clinical Leader